Search for: "Watson Pharmaceuticals, Inc"
Results 21 - 40
of 225
Sorted by Relevance
|
Sort by Date
8 Nov 2017, 7:26 am
Paul Insurance companies owe no duty to defend or indemnify Watson Pharmaceutical in governmental suits against the pharmaceutical company over the deceptive marketing of opioids. [read post]
18 Apr 2012, 8:15 pm
Watson Pharmaceuticals, Inc., et al. 1:12-cv-00321; filed March 30, 2012 in the Middle District of North Carolina • Plaintiffs: Allergan, Inc.; Duke University • Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
12 Dec 2010, 9:47 pm
Hunt • Defendants: IMPAX Laboratories, Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc. [read post]
4 Dec 2011, 8:52 pm
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Laboratories, Inc. [read post]
17 Jul 2011, 9:17 pm
Watson Pharmaceuticals et al. 1:11-cv-00607; filed July 8, 2011 in the District Court of Delaware • Plaintiffs: Abbott Laboratories; Abbott Respiratory LLC • Defendants: Watson Pharmaceuticals Inc.; Watson Laboratories Inc. [read post]
11 Nov 2015, 4:51 am
In this patent infringement action, Watson Laboratories, Inc.'s ("Watson") moved to dismiss several counts of the complaint filed by Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited (collectively, "Jazz"). [read post]
2 Dec 2009, 11:05 am
On December 2, 2009, the FTC announced an order settling charges that Watson Pharmaceuticals, Inc. [read post]
26 Apr 2012, 9:18 pm
Florida; Watson Pharmaceuticals Inc.; Watson Pharma Inc. [read post]
1 Apr 2016, 5:30 am
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
8 Jul 2011, 1:13 pm
The following is excerpted from a July 7, 2011 Watson press release published at PR Newswire: Watson Pharmaceuticals, Inc. [read post]
FTC and California AG Join in Challenging Reverse Payment Settlements in the Pharmaceutical Industry
6 Mar 2009, 7:03 am
Watson Pharm., Inc. et al., 09-cv-00598 (AHM) ("Watson"). [read post]
28 Jan 2015, 10:00 pm
Watson Pharmaceuticals, Inc., to the Federal Circuit “for further consideration in light of Teva Pharmaceuticals USA, Inc., v. [read post]
2 Mar 2014, 8:47 pm
Watson Laboratories Inc. et al. 1:14-cv-00268; filed February 27, 2014 in the District Court of Delaware • Plaintiff: Takeda Pharmaceuticals USA Inc. [read post]
11 Jul 2012, 9:50 pm
Watson Pharmaceuticals, Inc. [read post]
25 Apr 2013, 12:15 pm
In Bayer Healthcare Pharmaceuticals, Inc. v. [read post]
8 Jan 2012, 9:05 pm
Mylan, Inc. et al. 1:12-cv-00024; filed January 3, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.; Takeda Global Research and Development Center, Inc.; Watson Pharmaceuticals, Inc.; Andrx Labs, LLC • Defendants: Mylan, Inc.; Mylan Pharmaceuticals, Inc. [read post]
9 Aug 2009, 10:02 pm
Watson Pharmaceuticals, Inc. [read post]
17 Aug 2014, 9:59 pm
Watson Laboratories Inc. 1:14-cv-01003; filed July 31, 2014 in the District Court of Delaware • Plaintiffs: Unimed Pharmaceuticals LLC; Besins Healthcare Luxemborg SARL • Defendant: Watson Laboratories Inc. [read post]
6 Jan 2010, 9:12 pm
Cephalon Inc. has filed a civil suit for patent infringement against the generic drugmaker Watson Pharmaceuticals Inc. for its analeptic drug Nuvigil, generically known as Armodafinil. [read post]
17 Feb 2010, 8:00 am
Watson Pharmaceuticals Inc., Watson Laboratories Inc. and Watson Pharma Inc. [read post]
